Tech Company Financing Transactions
Larkspur Biosciences Funding Round
Larkspur Biosciences, based in Watertown, secured $35.5 million in investment from 3E Bioventures, Polaris Partners and Takeda Ventures.
Transaction Overview
Company Name
Announced On
5/24/2023
Transaction Type
Venture Equity
Amount
$35,500,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to focus on IND-enabling studies for its lead program, an approach to lipid remodeling to uncloak tumors as well as furthering the ongoing preclinical studies for its program targeting Pin1, a key mechanism of fibroblast differentiation to activate immune cells.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
480 Arsenal Way 125
Watertown, MA 02472
US
Watertown, MA 02472
US
Phone
Undisclosed
Website
Email Address
Overview
Larkspur was founded to develop precision immunotherapies targeting the key intersection between the tumor and the immune system. Our science is based on discoveries by our founders that the genetic deficiency of specific targets leads to autoimmunity -- a hallmark of targets that are important for cancer immunotherapy. With a proven track record of drug discovery and development, our team is passionate about solving hard problems and driven to deliver new medicines to cancer patients with significant unmet needs.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Catherine Peyton
Chief Scientific Officer
Krista Goodman
Browse more venture capital transactions:
Prev: 5/24/2023: Stepful venture capital transaction
Next: 5/24/2023: Swapp venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs